News Archive

2 July 2015

Tagworks and City of Hope secure US$ 465k ‘Breakthrough Award’ from US Department of Defense

For their proposal “Click chemistry-triggered activation of Antibody-Drug Conjugates”, Tagworks Pharmaceuticals and the research group of professor Paul Yazaki at…
Read more

10 March 2015

Tagworks features in Medicines

The latest edition of Medicines, a Dutch journal on drug development, features Tagworks Pharmaceuticals in the start-up sections. The article…
Read more

5 September 2014

Paper on improved antibody tag in Molecular Pharmaceutics

Developing an antibody tag with improved pharmacokinetics and stability allowed Tagworks to achieve increased tumor uptake of a radiolabeled pretargeting…
Read more

5 September 2014

Current Opinion in Chemical Biology features Tagworks review

Approaches that use in vivo chemistry to enable non-invasive molecular imaging and therapy are much sought after. Taking the recent…
Read more

7 July 2014

Tagworks presents at Gordon Research Conference

Marc Robillard, CEO of Tagworks Pharmaceuticals has been invited to speak during the Gordon Research Conference on Organic Reactions and…
Read more

16 December 2013

Tagworks and the University of Missouri-Columbia receive $ 585k NIH grant

Together with prof. Tom Quinn of the University of Missouri-Columbia, Tagworks succeeded in securing an Exploratory/Development grant from the US…
Read more

26 November 2013

Click to release – Tagworks publishes new approach to selective bioorthogonal release

By modifying the fastest and highly selective click reaction, the inverse-electron-demand-Diels-Alder reaction, Tagworks has achieved selective bioorthogonal release. This holds…
Read more

7 October 2013

Tagworks paper in Journal Nuclear Medicine

Tagworks’ pretargeting technology can boost tumor/non-tumor ratios compared with conventional radioimmunoimaging and -therapy. Published in Journal Nuclear Medicine 2013, 54,…
Read more

6 June 2013

Tagworks paper in Bioconjugate Chemistry

Antibody tags with 10-fold increased reactivity and enhanced in vivo stability – Check the paper on ‘Highly reactive trans-cyclooctene tags…
Read more

7 May 2013

Tagworks to present at SNMMI 2013 in Vancouver

On Wednesday June 12, Tagworks CEO Marc Robillard is a speaker in the “Probes for Oncology: Novel Oncology Probes and…
Read more

8 October 2012

New collaboration

Top-5 pharma company and Tagworks start collaboration on companion diagnostics.